Elder Pharma & Combe launch Vagisil range of feminine personal hygiene products in India

Elder Pharmaceuticals Ltd, one of the fastest growing pharmaceutical companies in the country, in association with New York based Combe Inc., a global brand leader in feminine care, has launched the Vagisil range of feminine personal hygiene products today in India.

Vagisil has been a world leader in feminine care for over four decades and is the most trusted and well accepted brand in over 40 countries across the globe. Combe Inc., and Elder Pharma are introducing three key solutions to help Indian women with their feminine needs: Vagisil Anti-Itch Creme, Vagisil Intimate Feminine Wash and Vagisil Intimate Feminine Lubricant.

Indian pharma firm 'Panacea Biotec' launches drug against polio in Nigeria

A leading Indian pharmaceutical company has launched a polio vaccine, POLPROTEC in Nigeria to help combat the spread of polio in Africa's top oil producer.

To make the vaccine easily available, Panacea Biotec is partnering Emzor pharma which has a strong footprint across Nigeria. The country is still facing the challenge of polio virus. 

During the launch, Panacea and Emzor made a public declaration of a Joint Polio-Free Mission "To contribute towards achieving the goal of global polio eradication and to ensure that no child will ever again be paralyzed by WPV or Vaccine-Derived Polio Virus (VDPV)."

New Non-Drowsy CLARITIN(R) Liqui-Gels(R) Now Available

Schering-Plough Corporation (NYSE: SGP) has announced the introduction of new CLARITIN(R) Liqui-Gels(R), the first and only non-drowsy allergy medicine in an easy-to-swallow liquid-filled capsule. Now available over-the-counter, CLARITIN(R) Liqui-Gels(R) provide powerful liquid relief for the worst allergy symptoms without causing drowsiness.

Novel Drug for Chronic Management of Hyperuricemia in Gout Patients

Teijin Pharma Limited announced the European launch of TMX-67 (febuxostat), a novel drug discovered by for the treatment of hyperuricemia in patients with gout.

Ipsen, a global biotechnology specialty care group and the TMX-67 licensee in Europe, and its sublicensee the Menarini Group, the first Italian pharmaceutical group in the world, have began marketing the product in Europe under the brand name ADENURIC(r).

Alcohol-free spray introduced in India to control spread of avian influenza

The Indian Foundation for Influenza (IFI) has introduced an alcohol-free hand disinfectant spray, ‘Clinister’ developed by the scientists of Japan which offers to tackle the avian influenza.

The formulation contains sodium citrate – a food additive added to acidic electrolyzed water as the principle ingredient along with other added ingredients like trisodium citrate, dehydratecetyl pyridinium chloride and lactose.

EU and US Regulatory Update - Tykerb/Tyverb® (lapatinib)

GlaxoSmithKline has submitted regulatory applications in Europe and the US related to Tykerb/ Tyverb (lapatinib) and its use in combination with trastuzumab to treat patients with HER2 (ErbB2)-positive metastatic breast cancer.

Osteoarthritis drug, Hyalgan launched in India

With the launch of Hyalgan (sodium hyaluronate), Lupin has forayed into the orthopaedic segment in India. Hyalgan is a therapy against degenerative joint disease-osteoarthritis. It is a type of intra-articular knee injection that delays the onset and progression of osteoarthritis in patients. It represents a painless, unique and qualitative therapeutic approach in the treatment of osteoarthritis available at affordable prices within the country.

Dr. Reddy's first to launch generic anaemia drug, Cresp

Dr. Reddy's Laboratories has announced that the company has launched a generic anaemia drug Cresp, which is the first of its kind biosimilar Darbepoetin alfa in the world.

New drug, Cresp is indicated in treating anaemia which is associated with chemotherapy and chronic kidney disease.

Dr Reddy's launches Strea C10 in India

Strea^TM C10 is a unique formulation of dermatological grade topical Vitamin C in the most potent and active form of L- Ascorbic acid at high concentration of 10% free from colouring agents, perfume and perspectives ensuring that active ingredient Vitamin C is delivered to skin in a precise, most stable and in purest form.

Dr. Reddy's Laboratories Ltd has launched Strea^TM C10, a New Age Vitamin C, in India. Strea^TM C10 uses microsphere technology.

Dr Reddy's launches new age Vit, Strea A15

Dr. Reddys Laboratories Ltd has launched Strea A15, a pure topical Retinol 0.15%.
i.e. a New Age Vitamin A, in India. Strea A15 uses microsphere
technology.

Strea A15 is a unique formulation of Vitamin A in Retinol form, the

bio active Retiniod for modulating skin function at concentration
of 0.15% in micospheres, free from colouring agents,
perfumeand preservatives ensuring that active ingredient,

Retinol is delivered to skin in precise, most stable & in purest form.

Strea A15 comes in a pack of 28 single doses of Vegicaps in a unique rotating disc, easy to use one per day for 28 consecutive days. The product is easy to apply, absorbs easily into skin and non greasy.

Strea A15 is recommended to use as a daily skin care agent to refine the skin texture

and improves cellular regeneration. The product is ideal to complement the ongoing skin care

programme as a maintenance agent for best skin rejuvenation.

 

GE's new compact, portable ECG machine - MAC i

Since 1965, GE has introduced technology innovation which has profoundly impacted clinical guidelines and ECG standards. Through its collaboration with world-leading cardiologists, GE continues to develop ECG products to the highest standard of quality.

Ind Swift to sell Roche's heart attack detection kits in India

Indian drugmaker Ind Swift Ltd said on Friday that it will sell heart attack detection kit developed by Swiss drugmaker Roche Holding in India.

Reacting to the news, shares of Ind Swift extended gains to more than 9 per cent. At 12:36 p.m (0708 GMT), the stock was up 6.14 per cent to 29.40 rupees in a Mumbai market that was up 0.6 per cent.

ACTT™ 'Allergy Drops' - Needle Free Allergy Treatment

Narrowing the gap between human and veterinary medicine.

AUSTIN, Texas, Feb. 9, 2012 /PRNewswire/ -- Bio-Medical Services has received USDA approval and is now offering allergy drop immunotherapy as an alternative method for administering allergy treatment for pet allergy patients. An in-house pilot study is now underway, and preliminary findings are expected in the Fall of 2012.

BioAlliance Pharma launches Oravig

BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, announces the launch in the United States of Oravig for the treatment of oropharyngeal candidiasis (OPC) in adults by its commercial partner, Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc.

GSK launches Convergence Pharmaceuticals for development of Novel High Value analgesic medicines

GSK has successfully launched Convergence Pharmaceuticals Ltd, a new company which focuses on the development of novel and high value analgesic medicines. Convergence Pharmaceuticals is an independent biotechnology company that has acquired clinical assets from GlaxoSmithKline ("GSK") to accelerate the clinical development of the Company's pipeline programme.

GE Healthcare launches GE centricity PACS reach

GE Healthcare has disclosed a newly designed low cost IT solution--GE centricity PACS reach, a Picture Archiving and Communication System (PACS) aimed at affordably digitizing India's 15,000-plus small diagnostic centers and hospitals, a market that's traditionally lower in clinical image volume but is growing at a tremendous pace in India's tier-II and tier-III cities. Centricity PACS reach endeavours to bring this market faster image access, greater efficiency and lower operational costs.

Helvoet Pharma set up 1st plant in India

Belgium's Helvoet Pharma, part of the Daetwyler Group, is setting up its first greenfield production facility in Khandala Industrial Area, Phase I on the Pune-Bangalore Highway with an investment of Rs 120 crore. The new plant, spread across 36,000 square meters, will come up in the newly developed MIDC Special Economic Zone near Pune and will serve as a strategic hub for exports to European countries.

RMS Regrow to launch orthopaedic and wound healing theraform in India

Regenerative Medical Services (RMS) Regrow, a cell therapy service provider focusing on orthopaedic and wound healing segments, is planning to launch a bio derived atelocollagen suitable for reconstruction of human tissue in wound management, in collaboration with its strategy partner, the Korea-based Sewon Cellontech.

KV Pharma gets FDA nod to re-launch product

KV Pharmaceutical Co got U.S. regulatory approval to reintroduce its first product that was pulled out of market due to manufacturing problems, and expects to begin shipments next week, sending its shares up as much as 92 percent.

Eli Lilly on Launch of Humapen Luxura Hd, an easy-to-use Insulin Delivery Device for Diabetes Patients

Eli Lilly and Company ("Lilly") announced the launch of HumaPen® LUXURA™ HD, an easy-to-use insulin delivery device for patients who may require the precision of half-unit dosing (HD). The new dosing feature enhances safety and accuracy in maintaining glycemic control for patients, especially children with diabetes.